Mariner’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-29,329
| Closed | -$151K | – | 1126 |
|
|
2019
Q2 | $151K | Hold |
29,329
| – | – | ﹤0.01% | 1061 |
|
|
2019
Q1 | $106K | Hold |
29,329
| – | – | ﹤0.01% | 999 |
|
|
2018
Q4 | $180K | Hold |
29,329
| – | – | ﹤0.01% | 782 |
|
|
2018
Q3 | $171K | Hold |
29,329
| – | – | ﹤0.01% | 775 |
|
|
2018
Q2 | $125K | Sell |
29,329
-20
| -0.1% | -$101 | ﹤0.01% | 765 |
|
|
2018
Q1 | $129K | Hold |
29,349
| – | – | ﹤0.01% | 609 |
|
|
2017
Q4 | $154K | Sell |
29,349
-23,675
| -45% | -$145K | 0.01% | 548 |
|
|
2017
Q3 | $325K | Sell |
53,024
-7,694
| -13% | -$48.7K | 0.01% | 404 |
|
|
2017
Q2 | $439K | Sell |
60,718
-3,766
| -6% | -$23.2K | 0.02% | 359 |
|
|
2017
Q1 | $342K | Buy |
64,484
+14,786
| +30% | +$99.8K | 0.01% | 439 |
|
|
2016
Q4 | $357K | Hold |
49,698
| – | – | 0.02% | 419 |
|
|
2016
Q3 | $465K | Sell |
49,698
-2,075
| -4% | -$17.2K | 0.02% | 383 |
|
|
2016
Q2 | $327K | Buy |
51,773
+100
| +0.2% | +$643 | 0.02% | 401 |
|
|
2016
Q1 | $285K | Buy |
51,673
+14,031
| +37% | +$52.8K | 0.02% | 404 |
|
|
2015
Q4 | $210K | Buy |
37,642
+20
| +0.1% | +$132 | 0.01% | 411 |
|
|
2015
Q3 | $318K | Buy |
37,622
+3,293
| +10% | +$55.7K | 0.01% | 394 |
|
|
2015
Q2 | $519K | Hold |
34,329
| – | – | 0.02% | 334 |
|
|
2015
Q1 | $550K | Sell |
34,329
-20
| -0.1% | -$356 | 0.05% | 234 |
|
|
2014
Q4 | $612K | Buy |
34,349
+3,000
| +10% | +$37.4K | 0.06% | 219 |
|
|
2014
Q3 | $315K | Buy |
31,349
+2,020
| +7% | +$24.5K | 0.04% | 264 |
|
|
2014
Q2 | $458K | Hold |
29,329
| – | – | 0.05% | 237 |
|
|
2014
Q1 | $544K | Hold |
29,329
| – | – | 0.07% | 207 |
|
|
2013
Q4 | $560K | Buy |
+29,329
| New | +$595K | 0.07% | 219 |
|
Other funds holding PETX
Mariner's PETX Position: Q3 2019 in Review
Mariner sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 29,329 shares — an estimated $151K sold.
Mariner first reported a position in PETX in Q4 2013 and held it in 23 quarters. The position peaked at $612K in Q4 2014. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.
- Mariner reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
- Mariner sold 29,329 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $151K.
- Mariner first reported a position in Aratana Therapeutics, Inc. in Q4 2013 and held it in 23 quarters.
- Mariner's Aratana Therapeutics, Inc. position peaked at $612K in Q4 2014.
- 2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.
Based on Mariner's 13F filing for Q3 2019, filed 13 Nov 2019.